ARCHIVES

Lenalidomide Found Effective For Lymphoma In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting.

June 13, 2008

In Brief: Levine Leaves NIH For Pittsburgh; Fischbach Leaves Harvard For NIH; NCI Researcher Dies

June 12, 1998

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

Proposed Guidelines For Clinical Tests Of Oncologic Drugs

November 28, 1975

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

GAO Offers Two Suggestions For Plant Screening

April 4, 1980